UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2020
Commission File Number: 001- 39167
Molecular Data Inc.
5/F, Building 12, 1001 North Qinzhou Road
Xuhui District, Shanghai 201109
People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
EXHIBIT INDEX
Exhibit No. |
| Description |
99.1 |
| Press Release – Molecular Data Inc. Announces Private Placement of up to US$5.0 Million Convertible Debentures |
99.2 |
| Securities Purchase Agreement dated October 9, 2020 between Molecular Data Inc. and YA II PN, Ltd. |
99.3 |
| Registration Rights Agreement dated October 9, 2020 between Molecular Data Inc. and YA II PN, Ltd. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Molecular Data Inc. | ||
|
|
|
|
|
|
|
|
| By | : | /s/ Zheng Wang |
| Name | : | Zheng Wang |
| Title | : | Director and Chief Executive Officer |
Date: October 13, 2020